NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
17.46
-0.01 (-0.06%)
Apr 25, 2025, 4:00 PM EDT - Market closed

NAMS Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1,9242,751920889139-
Market Cap Growth
199.19%199.19%3.44%537.58%--
Enterprise Value
1,0902,329501796144-
Last Close Price
17.5225.7011.1710.909.75-
PS Ratio
36.2860.3865.268.66--
PB Ratio
2.503.633.192.072.46-
P/TBV Ratio
2.543.643.192.072.46-
P/FCF Ratio
---85.12--
P/OCF Ratio
---83.36--
EV/Sales Ratio
23.9351.1235.567.75--
EV/FCF Ratio
---76.18--
Debt / Equity Ratio
0.000.00000.00-3.26
Debt / FCF Ratio
---0.01--
Asset Turnover
0.080.080.030.38--
Quick Ratio
8.008.006.8613.035.810.61
Current Ratio
8.078.076.9513.265.960.72
Return on Equity (ROE)
-46.20%-46.20%-49.25%-9.30%-159.01%-
Return on Assets (ROA)
-18.19%-18.19%-27.70%-0.81%-55.71%-
Return on Capital (ROIC)
-21.06%-21.06%-31.82%-0.91%-66.25%-
Earnings Yield
-12.56%-8.78%-19.24%-2.55%-29.97%-
FCF Yield
-8.28%-5.79%-15.36%1.18%-21.18%-
Buyback Yield / Dilution
-14.84%-14.84%-333.20%-72.75%-119.58%-
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q